Invasive Pulmonary Aspergillosis and Tuberculosis Complicated by Hemophagocytic Lymphohistiocytosis – Sequelae of COVID-19 in a Liver Transplant RecipientCase report Published on 2022-05-012022-10-05 Journal: Journal of Clinical and Experimental Hepatology [Category] 바이오마커, [키워드] aspergillosis COVID-19 disease disseminated tuberculosis hemophagocytic lymphohistiocytosis High-dose immune dysfunction Immunosuppression increase increased risk Infection invasive invasive aspergillosis liver liver transplant Liver transplantation opportunistic infection pulmonary recipient risk severe COVID-19 Steroids Transplant [DOI] 10.1016/j.jceh.2021.12.002 [Article Type] Case report
Bacillus Calmette-Guerin (BCG): the adroit vaccineReview Published on 2021-02-082022-10-27 Journal: AIMS Microbiology [Category] COVID-19, [키워드] Activation all-cause mortality approach Bacillus Calmette-Guérin BCG clinical trial correlation COVID-19 COVID-19 pandemic COVID-19 transmission disseminated tuberculosis Effect Effects Efficacy epidemiological Epidemiological study Evidence Fever form H1N1 herpes simplex Heterologous highlight Host HPV human vaccine humans implication Infants influence Influenza virus innate immune memory investigated mechanism mortality rate Neonatal non-specific non-specific effects, vaccine objective offered papilloma protective effect pulmonary tuberculosis reduce Research respiratory syncytial virus Result RSV significantly subject suggested the vaccine thought Tuberculosis vaccination Vaccination strategy Vaccine viral infection viral infections virus while [DOI] 10.3934/microbiol.2021007 PMC 바로가기 [Article Type] Review
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosisShort communication Published on 2020-10-012022-10-05 Journal: Transfusion and apheresis science : official journ [Category] SARS, 치료법, 치료제, [키워드] anti-cytokine antiviral drug approach clinical decision Comorbidities Comorbidity convalescent COVID-19 COVID-19 pandemic COVID-19 patient disseminated tuberculosis drug combination high risk immune kidney malignancy Myelodysplastic plasma Plasmapheresis required syndrome the SARS-CoV-2 virus therapy Treatment Tuberculosis [DOI] 10.1016/j.transci.2020.102821 [Article Type] Short communication